Factor Xa based anticoagulant compositions

Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 696, 435212, 435226, 530381, 514 2, 514 12, 514 21, A61K 37547, A61K 3702, C12N 1501, C07K 1300

Patent

active

051205378

ABSTRACT:
An anticoagulant composition containing an effective amount of factor Xa having the active serine site inactivated that functions rapidly and effectively in vivo to suppress coagulation. In a preferred embodiment, Factor Xa, a serine esterase that forms a complex with Factor Va, Ca++, and phospholipid to catalyze prothrombin activation, is first inactivated with an active site inhibitor, such as dansyl-glu- gly-arg-chloromethyl ketone, to form inactivated factor Xa. In another embodiment, Factor Xa is expressed from a gene sequence wherein the portion encoding the active serine region is modified. The inactivated protein retains the ability to bind to endogenous factor Va in vivo, and has a half-life of approximately ten hours. Administration of inactive factor Xa to the blood of a patient results in the formation of inactive factor Xa-Va complexes in vivo, thereby inhibiting coagulation.

REFERENCES:
patent: 4775624 (1988-10-01), Bang et al.
patent: 4832849 (1989-05-01), Cardin
Leytus et al., Biochemistry, vol. 25, No. 18, 1986, pp. 5098-5102.
Nesheim et al., J. Biol. Chem., vol. 256, No. 13, 1981, pp. 6537-6540.
Lollar et al., Arch. Biochem. Biophys., vol. 233, No. 2, 1984, pp. 438-446.
Leytus et al., PNAS U.S.A., vol. 81, 1984, pp. 3699-3702.
Husten et al., J. Biol. Chem., vol. 262, No. 27, 1987, pp. 12953-12961.
Taylor et al., Thrombosis Research 36, 177-185 (1984).
Taylor et al., J. Clin. Invest. 79, 918-925 (1987).
Nawroth and Stern, Biol. Abstr. 81(11): AB-131 of J. Exp. Med. 163(3): 740-745 (1986).
Esmon et al., "Anticoagulation Proteins C and S", The New Dimensions of Warfarin Prophylaxis ed. Wessler, Becker, and Nemerson, pp. 47-54 (Plenum Press, NY 1987).
Mann, Progress in Hemostasis and Thrombosis, pp. 1-23 (Grune & Stratton 1984).
Hanson and Harker, Proc. Natl. Acad. Sci. USA 85, 3184-3188 (May 1988).
Kaufmann et al., J. Biol. Chem. 261(21), 9622-9628 (1986).
Skogen et al., J. Biol. Chem. 259(4), 2306-2310 (1984).
Jorgensen, M. J., et al., J. Biol. Chem. 262(14), 6729-6734 (1987).
Ehrlich, H. J., et al., J. Biol. Chem. 264(24), 14298-14304 (1989).
Lin, S. W., et al., J. Biol. Chem. 265(1), 144-150 (1990).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Factor Xa based anticoagulant compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Factor Xa based anticoagulant compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Factor Xa based anticoagulant compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1803344

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.